The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
LAURUSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts less than Nifty Midcap 150 and 3.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mirae Asset Mutual Fund disclosed under SEBI SAST Regulation 29(2) that it acquired 858,801 equity shares (0.16%) of Laurus Labs on July 29, 2025 through open market purchases. This takes Mirae's total holding in Laurus Labs from 10,100,133 shares (1.87%) to 10,958,934 shares (2.03%). The acquirer is not part of the promoter or promoter group. The disclosure was filed by Mirae Asset Investment Managers (India) Private Limited, the asset management arm of Mirae Asset Mutual Fund.
This is a routine incremental purchase by a mutual fund entity and does not cross any major regulatory threshold. No material impact on share price or shareholder structure is expected, though it signals continued institutional interest in Laurus Labs.